Latest news for  (OTC:LXRCF) Stock

Earnings

News

Tandy Leather Factory Q3 EPS $(0.02) Down From $0.08 YoY, Sales $17.4M Down From $17.5M YoY

WIIM

VTSI

VirTra shares are trading higher after the company reported better-than-expected Q3 financial results.

BYNO

byNordic Acquisition Extends Deadline To Complete Business Combination From Nov. 12 To Dec. 12

Quince Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the presentation of two posters at the 2024 International Congress for Ataxia Research (ICAR) of data from its prior Phase 3 ATTeST (Ataxia-Telangiectasia Trial with the EryDex SysTem; #IEDAT-02-2015/<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT02770807&amp;esheet=54151295&amp;newsitemid=20241112415817&amp;lan=en-US&amp;anchor=NCT02770807&amp;index=1&amp;md5=4ffadd5fda4ab5ea7056e04e622cc722">NCT02770807</a>) clinical trial of the company's lead asset, EryDex (intra-erythrocyte dexamethasone sodium phosphate), for the treatment of Ataxia-Telangiectasia (A-T).

Biotech

General

QNCX

Quince Therapeutics Presents Data From Prior Phase 3 ATTeST Clinical Trial At 2024 International Congress For Ataxia Research

GOVX

GeoVax Labs shares are trading lower. The company reported Q3 financial results.

Earnings Misses

MTTR

Matterport Q3 2024 Adj. EPS $(0.01), Inline, Sales $43.800M Miss $43.900M Estimate

Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. The company reported quarterly sales of $14.616 million which missed the analyst consensus estimate of $15.883 million by 7.97 percent. This is a 18.67 percent increase over sales of $12.316 million the same period last year.

Earnings Beats

Avino Silver & Gold Mines Q3 2024 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $14.616M Miss $15.883M Estimate

SNES

SenesTech shares are trading higher after the company reported a year-over-year increase in Q3 EPS results.

i-80 Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#AMEX">IAUX</a>) reported $11.51 million in sales this quarter. This is a 12.91 percent decrease over sales of $13.21 million the same period last year.

IAUX

i-80 Gold Q3 Sales $11.51M Down From $13.21M YoY

WVVI

Willamette Valley Vineyards Diluted $(0.17) Inline YoY; Revenue $9.370M Up From $9.348M YoY

SKIN

The Beauty Health Company shares are trading higher after the company reported better-than-expected Q3 revenue results.

<a href="https://pr.report/45xt">Gladstone Capital Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLAD#NASDAQ">GLAD</a>) (the "Company") announced today that its board of directors declared the following additional supplemental cash distribution to common stockholders payable in December 2024.
Common Stock: A supplemental distribution of $0.40 per share of common stock in December 2024 payable per the table below.
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Record Date</td>
<td>Payment Date</td>
<td>Cash Distribution</td>
</tr>
<tr>
<td>December 4</td>
<td>December 18</td>
<td>$0.40</td>
</tr>
</tbody>
</table>
</figure>
On November 4, 2024, the Company announced the sale of its equity interest and the prepayment of its debt investment in Antenna Research Associates, Inc. As a result of the transaction, the Company realized a significant gain on its equity investment.

Dividends

GLAD

Gladstone Capital Announces $0.40 Supplemental Cash Distribution

TSS, Inc. (OTCQB:<a href="https://www.benzinga.com/stock/TSSI#OTCQB">TSSI</a>), a leading data center services company in the AI and high-performance computing infrastructure and services market, today announced that its shares of common stock have been approved for listing to The Nasdaq Capital Market ("Nasdaq"). Trading on the exchange will commence effective with the open of business on November 14, 2024, under the Company's current ticker symbol, "TSSI."
The Company's common stock will continue to trade on the OTCQB until the close of the market on November 13, 2024.Shareholders are not required to take any action as a result of the uplisting,

TSSI

TSS, Inc. Announces Uplisting To The Nasdaq Capital Market, Effective With The Open Of Business On November 14, 2024

CXApp's AI-powered platform, including CXAI (Sky) and CXAI VU (Skyview), enhance employee experience at scale for large enterprises
PALO ALTO, CA / ACCESSWIRE / November 12, 2024 / <a href="https://pr.report/47hx">CXApp Inc.</a> (NASDAQ:<a href="https://www.benzinga.com/stock/CXAI#NASDAQ">CXAI</a>), the leading provider of AI-driven employee experience solutions, today announced the availability of its flagship product, CXAI, and its generative AI-based analytics platform, CXAI VU, on AWS Marketplace, a curated digital catalog that enables customers to easily find, buy, and deploy software. By leveraging CXApp's cross-platform application CXAI and its cutting-edge analytics platform, CXAI VU, businesses can automate and personalize employee interactions at scale, improving employee engagement, reducing operational costs, and driving productivity and collaboration.
The CXAI technology platform represents a shift towards an AI-centric approach in workplace innovation. CXAI seamlessly integrates customer experience (CX) with artificial intelligence (AI) focused on the employee to deliver solutions that transform the way work happens. With the addition of CXAI VU, the platform also offers generative AI-based analytics, allowing organizations to analyze large data sets, generate actionable insights, and make real-time decisions. This leads to more intuitive and efficient workspaces, ultimately resulting in happier and more engaged employees.

CXAI

CXApp Inc. Announces Availability Of AI-Driven Employee Experience Solutions On AWS Marketplace

CaliberCos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWD#NASDAQ">CWD</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.13) by 107.69 percent. This is a 106.25 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $11.30 million which beat the analyst consensus estimate of $6.19 million by 82.58 percent. This is a 33.62 percent decrease over sales of $17.02 million the same period last year.

CaliberCos Q3 EPS $0.01 Beats $(0.13) Estimate, Sales $11.30M Beat $6.19M Estimate

FBLG

FibroBiologics, Inc. Reports Net Loss $8.1M For Nine Months Ended Sept. 30

Largo Q3 EPS $(0.16) Up From $(0.19) YoY; Q3 Sales $29.9M Down From $43.9M YoY

HF Foods Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFFG#NASDAQ">HFFG</a>) reported quarterly losses of $(0.07) per share. This is a 333.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $298.39 million which beat the analyst consensus estimate of $290.07 million by 2.87 percent. This is a 6.02 percent increase over sales of $281.45 million the same period last year.

HFFG

HF Foods Group Q3 EPS $(0.07) Down From $0.03 YoY, Sales $298.39M Beat $290.07M Estimate

Tempest Therapeutics, Inc. - Common Stock

TPST

Tempest Therapeutics Q3 EPS $(0.41) Misses $(0.35) Estimate

XBP Europe Holdings Q3 EPS From Cont Ops $(0.04) Up From $(0.05) YoY, Sales $35.33M Down From $37.43M YoY

Comments

News

Latest news for (OTC:LXRCF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga